Donate Now
  • What We're Working On
Using Artificial Intelligence to Streamline Research on Rheumatoid Arthritis Treatments
Research-Stream-AI-Study_425x296
Scientific Study Title:
STREAM-AI: Systematic Trial Record Extraction and Matching using Artificial Intelligence to Advance Living Guidelines in Rheumatoid Arthritis
Start Date:
  • 2025
End Date:
  • 2027
Research Category
Tags

Why do this research?

Doctors and rheumatoid arthritis patients rely on clear, current information when choosing the best treatments. New research is published constantly, and each clinical trial may produce many separate scientific papers. This makes it time-consuming and difficult to sort through and stay on top of all the information. This project, STREAM-AI (Systematic Trial Record Extraction and Matching using Artificial Intelligence), will aim to make this process faster and more accurate using artificial intelligence.

What will be done?

This project will create a new artificial intelligence tool that can:

  • Recognize multiple scientific articles coming from the same clinical trial.
  • Automatically sort each trial by the treatment being studied.
  • Provide an easy-to-use online system where human experts can double-check the artificial intelligence’s decisions.
  • By combining medical and artificial intelligence expertise, this project will help keep rheumatoid arthritis treatment recommendations up to date more efficiently, ensuring that patients and healthcare providers have access to the best available evidence.

The Research Team

Principal Investigator

  • Glen Hazlewood, MD, PhD, FRCPC, Research Scientist, Arthritis Research Canada (University of Calgary)

Co-Investigator

  • Mina Aminghafari, PhD (University of Calgary)

Trainees

  • Kamso Mujaab, PhD, (University of Calgary)
  • Youssef Abdelwahab, (University of Calgary)
  • Archana Senthil (University of Calgary)

Who Funded This Research?

McCaig Institute for Bone and Joint Health

How Can People Get Involved?

The work is embedded within several large international consortiums, including Cochrane, and rheumatology guideline groups.

Media and Infographics

Related Research

What We're Working On Right Now

Exploring a New Immune Cell Therapy for People with Autoimmune Diseases

Systemic sclerosis and systemic lupus erythematosus are serious autoimmune diseases that can cause damage to many organs including the skin, lungs and kidneys. In this project, we will study a new type of treatment that may better control these diseases by targeting the immune cells that cause them. If successful, it could reduce inflammation, slow or stop disease progression, and may even help reset the immune system, so that some patients no longer need long-term immune-suppressing medications.
Read More

Understanding how scleroderma affects people over time

People living with scleroderma experience challenges such as pain, disability, and mental health concerns, but we still don’t know much about how these problems change over time or why some people do better than others. For this research project, our goal is to improve our understanding of how scleroderma affects people’s daily lives and identify factors that may predict changes in their health.
Read More

How can we help Canadians age at home to improve health outcomes and support a sustainable healthcare system?

As Canada’s population ages, home care is important for helping older adults remain safely within their homes. Our research team is linking data from the Canadian Longitudinal Study on Aging with health records in British Columbia, Ontario, and New Brunswick, to track patterns of paid and unpaid home care use over time.
Read More